Q3 2025 Earnings Call Transcript October 29, 2025 Emergent BioSolutions Inc. beats earnings expectations. Reported EPS is ...
Discover Q3 2025 highlights for Emergent BioSolutions: raised revenue guidance, strong naloxone sales, and margin growth.
TipRanks on MSN
Emergent BioSolutions Raises Full-Year Revenue Guidance
Emergent Biosolutions ( (EBS) ) has shared an announcement. On October 29, 2025, Emergent BioSolutions reported its financial results for the third quarter of 2025, with total revenues of $231.1 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback